Davalo, Milagros;
Cabrejos, Maria;
Delgado, Cesar;
Padilla, Martin;
Vejarano, Carlos;
Vera, Romina;
Huaringa-Marcelo, Jorge;
Montes-Alvis, Jose;
Goicochea-Lugo, Sergio;
Becerra-Chauca, Naysha;
Nieto-Gutierrez, Wendy.
This article summarizes the clinical practice guidelines (CPG) for the diagnosis and treatment of chronic infection of hepatitis viral C of the Peruvian Health Social Security (EsSalud). To provide clinical recommendations based on evidence for the diagnosis and treatment of chronic infection of hepatiti...
The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy (ASTCT) partnered with its Transplant Infectious Disease Special Interest Group (TID-SIG) to update its 2009 compendium-style infectious disease guidelines for hematopoietic cell transplantation (HCT). A new...
The Practice Guidelines Committee of the American Society for Transplantation and Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to update its 2009 compendium-style infectious diseases guidelines for the care of hematopoietic cell transplant (HCT) recipients. A n...
Según estimaciones de la Organización Mundial de la Salud (OMS), en el
2015 257 millones de personas en el mundo tenían la infección crónica por el
virus de la hepatitis B (VHB) y 900 000 fallecieron a causa de ella, en la mayor
parte de los casos de cirrosis o carcinoma hepatocelular. La mayoría d...
Chalmers, James;
Crichton, Megan;
Goeminne, Pieter;
Cao, Bin;
Humbert, Marc;
Shteinberg, Michal;
Antoniou, Katerina;
Suppli Ulrik, Charlotte;
Parks, Helen;
Wang, Chen;
Vandendriessche, Thomas;
Qu, Jieming;
Stolz, Daiana;
Brightling, Christopher;
Welte, Tobias;
Aliberti, Stefano;
Simonds, Anita;
Tonia, Thomy;
Roche, Nicolas.
Hospitalised patients with coronavirus disease 2019 (COVID-19) as a result of SARS-CoV-2 infection have a high mortality rate and frequently require noninvasive respiratory support or invasive ventilation. Optimising and standardising management through evidence-based guidelines may improve quality of ca...
Wu, Lei;
Chen, Yaolong;
Ma, Yanfang;
Yang, Zifeng;
Yang, Nan;
Denga, Wenze;
Chen, Yuanbin;
Sun, Yuanyuan;
Li, Yimin;
Lin, Lin.
Influenza is a major public health problem worldwide. Mutations and resistance development make the use of antiviral therapy challenging. Chinese patent medicines are often used to treat influenza in China and well tolerable. However, the misuse of Chinese patent medicines is common. We therefore aimed t...
Rochwerg, Bram;
Agarwal, Arnav;
Zeng, Linan;
Leo, Yee-Sin;
Appiah, John Adabie;
Agoritsas, Thomas;
Bartoszko, Jessica;
Brignardello-Petersen, Romina;
Ergan, Begum;
Ge, Long;
Geduld, Heike;
Gershengorn, Hayley B;
Manai, Hela;
Huang, Minhua;
Lamontagne, François;
Kanda, Seema;
Kawano-Dourado, Leticia;
Kurian, Linda;
Kwizera, Arthur;
Murthy, Srinivas;
Qadir, Nida;
Siemieniuk, Reed;
Silvestre, Maria Asuncion;
Vandvik, Per Olav;
Ye, Zhikang;
Zeraatkar, Dena;
Guyatt, Gordon.
Clinical question: What is the role of remdesivir in the treatment of severe covid-19? This guideline was triggered by the ACTT-1 trial published in the New England Journal of Medicine on 22 May 2020.Remdesivir has received worldwide attention as a potentially effective treatment for severe covid-19. Aft...
This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in ...
Diagnostic Clinique/diagnostic,
Betacoronavirus/effets des médicaments et des substances chimiques,
Infections à coronavirus/diagnostic,
Pneumopathie virale/diagnostic,
Hypoxie/diagnostic,
Acuité des besoins du patient,
Infections à coronavirus/traitement médicamenteux,
Pneumopathie virale/traitement médicamenteux,
Dexaméthasone/usage thérapeutique,
Allaitement naturel,
Antiviraux/usage thérapeutique,
Hydroxychloroquine/usage thérapeutique,
Colchicine/usage thérapeutique,
Plasma sanguin/immunologie,
Darunavir/usage thérapeutique,
Interférons/usage thérapeutique,
Pratique factuelle/méthodes
La finalidad de esta guía es establecer un referente nacional para orientar la toma de decisiones clínicas basadas en recomendaciones sustentadas en la mejor evidencia disponible. Esta guía pone a disposición del personal del primer, segundo y tercer nivel de atención las recomendaciones basadas en ...
Generar recomendaciones basadas en la mejor evidencia disponible acerca del
manejo clínico de las personas con infección crónica por virus de Hepatitis C, relevando los grupos
de mayor riesgo y contribuyendo a una mejor gestión de los recursos....
